Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 53 (SLC25A53) is a mitochondrial inner membrane transporter that belongs to the SLC25 family of mitochondrial carrier proteins, which are responsible for transporting a variety of metabolites, nucleotides, and cofactors between the cytosol and the mitochondrial matrix[1][2][4][6][8]. SLC25A53 is classified as an orphan transporter, meaning its precise physiological substrates are not definitively identified, although it is predicted to participate in NAD transmembrane transport[5]. It is expressed in mitochondria as a multi-pass membrane protein[1]. Genetic associations suggest possible links to progressive external ophthalmoplegia and spastic paraplegia[5]. No direct drug interactors or validated roles as a drug target have been described in the current literature and drug databases[5][7]. As a member of the mitochondrial carrier family, SLC25A53 may play roles in energy metabolism and mitochondrial maintenance, but most of its biological and clinical roles remain to be clarified[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 53 (SLC25A53).